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Monitoring System (2009–2011)
Saba W. Masho1,2,3*, Amani Bassyouni1 and Susan Cha1

Abstract
Background: Although adequate folic acid or multivitamins can prevent up to 70 % of neural tube defects,
the majority of U.S. non-pregnant women of childbearing age do not use multivitamins every day. Factors
influencing consistent multivitamin use are not fully explored. This study aims to investigate the association
between pre-pregnancy body mass index (BMI) and multivitamin use before pregnancy using a large,
nationally representative sample of women with recent live births.
Methods: The national 2009–2011 Pregnancy Risk Assessment Monitoring System data were analyzed. The
sample included women with recent singleton live births (N = 104,211). The outcome of interest was
multivitamin use which was categorized as no multivitamin use, 1–3 times/week, 4–6 times/week, and daily
use. Maternal BMI was examined as underweight (<18.50 kg/m2), normal weight (18.50–24.99 kg/m2),
overweight (25.00–29.99 kg/m2), and obese (≥30.00 kg/m2). Multinomial logistic regression was conducted,
and adjusted odds ratios and 95 % confidence intervals were calculated.
Results: Compared to women with normal weight, overweight and obese women had significantly increased
odds of not taking multivitamins after adjusting for confounding factors. Further, the lack of multivitamin use increased
in magnitude with the level of BMI (ORoverweight = 1.2, 95 % CI = 1.1–1.3; ORobese = 1.4, 95 % CI = 1.2–1.5).
Conclusions: Obese and overweight women were less likely to follow the recommendation for preconception
multivitamin use compared to normal weight women. All health care professionals must enhance preconception care
with particular attention to overweight and obese women. Preconception counseling may be an opportunity to
discuss healthy eating and benefits of daily multivitamin intake before pregnancy.
Keywords: Obesity, Body mass index, Vitamins, Dietary supplements, Preconception care, PRAMS

Background
Multivitamin use has increased over the past decade and
is the most commonly used dietary supplement in the
United States [1]. According to the Centers for Disease
Control and Prevention (CDC), approximately 34 %
of women aged 20–39 used a dietary supplement
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containing folic acid and 30 % reported using supplemental vitamin D in 2003–2006 [2]. Additionally, nationally representative data that come from the
Behavioral Risk Factor Surveillance System (BRFSS)
indicate 78 % of pregnant women and 47 % of nonpregnant women of childbearing age (18–44) use
multivitamins daily [3]. Since 1991, the U.S. Public
Health Service has recommended that all women who
plan on becoming pregnant consume 400 μg of folic
acid daily beginning one month before trying to get
pregnant [4, 5]. However, a recent report from the
CDC finds that more than 63 % of women do not

© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Masho et al. BMC Pregnancy and Childbirth (2016) 16:210

take multivitamins during the month before pregnancy [6]. The lack of multivitamin use is a public
health concern given that adequate folic acid or multivitamins can prevent 50to 70 % of pregnancies affected by serious birth defects, (i.e., spina bifida and
anencephaly) [7]. For instance, one hospital-based
case–control study reported the use of folic acid
(0.4 mg daily for three months before and after conception, and continuing for at least one month) was associated with decreased neural tube defects (OR = 0.32,
95 % CI = 0.17–0.58), but the protective effects of folic
acid supplementation was attenuated for overweight or
obese women [8]. Similarly, a recent Cochrane review,
women receiving folic acid with micronutrients were
less likely to have infants with neural tube defects than
women receiving other or same micronutrients without
folic acid (RR = 0.31, 95 % CI = 0.16–0.60; RR = 0.29,
95 % CI = 0.12–0.70) [9].
Additionally, prenatal iron deficiency anemia during
pregnancy has detrimental effects on infant mental development. A cohort study that followed women during
the last trimester to 24 months after delivery reported a
lower mental development index among children exposed to prenatal iron deficiency anemia at 12, 18, and
24 months of age; however, supplementation with sufficient iron was found to be protective [10]. Prenatal
vitamin intake during pregnancy has been shown to significantly reduce the risk of birth defects, low birth
weight, small for gestational age, and spontaneous preterm birth [11–14].
Despite the benefits of multivitamins or folic acid use
before pregnancy, non-adherence to recommendations
has been observed in some populations. A large proportion of women who are younger (under 20 years of age),
of racial/ethnic minority group, or without history of
neural tube defects do not take folic acid supplements
before pregnancy [15]. Other risk factors for inconsistent
or no use of multivitamin during pregnancy include low
income and below high school educational attainment
[3, 16]. One study conducted among African-American
and Hispanic women identified adverse side effects, large
size of pills, and bad taste and smell as possible barriers
to multivitamin use [17]. Lack of knowledge regarding
multivitamin use, dose, duration, timing and efficacy can
also lead to non-adherence to multivitamin use during
pregnancy [18]. On the other hand, Kimmons et al. reported that obese women were less likely to use multivitamins than normal weight women [19].
To the authors’ knowledge, only a few studies have
assessed the relationship between obesity and multivitamin use [20–22]. For example, a nested retrospective cohort study conducted by Farah et al. found that obese
and overweight women reported less folic acid use before pregnancy compared to women of normal weight
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[20]. In yet another study, Case et al. used data from
the Texas Behavioral Risk Factor Surveillance System
(1999–2003) and found that obese but not overweight
women were less likely to take folic acid every day
compared to normal weight/underweight women [21].
Kimmons et al. examined the association between
body mass index (BMI) and serum micronutrient
levels among U.S. adults and found that premenopausal women who were overweight and obese were
more likely to have low levels of micronutrients (e.g.,
folate) than normal weight premenopausal women
[22]. Decreased folic acid intake may be due to unplanned pregnancies and failed contraceptive methods
prevalent in obese women [23]. Although findings in
these studies provide critical evidence, these studies
have notable limitations. The study by Farah et al.
had a small sample size (n = 288) and included only
Caucasian women, making it less generalizable to minorities who may be at risk for poor pregnancy outcomes [20]. Similarly, Case et al. only considered
women from Texas and excluded those who were
younger than 18 years old [21]. In the study by Kimmons
et al., micronutrient intake was not taken into consideration, and any adult women (≥19 years) were categorized
as premenopausal if they reported menstruation in the
previous 12 months, possibly including older women who
were no longer of reproductive age (15–44) [22]. The observed shortcomings in the study designs, problems related to small sample sizes and homogenous study
populations, warrant further investigation of the relationship between obesity and multivitamin use.
This study aims to investigate the association between
pre-pregnancy BMI and multivitamins use before pregnancy using a large, nationally representative sample of
women with recent live births.

Methods
The 2009–2011 Pregnancy Risk Assessment Monitoring
System (PRAMS) [24] was analyzed to assess the relationship between pre-pregnancy BMI and multivitamin
use before pregnancy. PRAMS is an ongoing national
surveillance program through the CDC in collaboration
with participating state health departments. Data on
women with recently delivered live-born infants are
drawn from state birth certificate files. PRAMS utilizes a
complex multistage sampling design and oversamples
women from minority groups and high risk populations
to ensure adequate numbers for analyses (e.g., low
weight births). Accordingly, oversampling is accounted
for by analysis weights provided by CDC to obtain nationally representative estimates. Women are contacted
by mail or telephone to participate, and information regarding their attitudes, behaviors, and experiences before
and during pregnancy, and a few months after birth are
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obtained from those who consent to participate. In order
to ensure comparability of data, PRAMS establishes
standardized surveillance methods and tools for data
collection.
A total of 112,358 women (unweighted N) participated
in PRAMS for 2009 to 2011. For this analysis women
with singleton live births and valid responses to questions on pre-pregnancy BMI and multivitamin use a
month prior to pregnancy were included. The study
sample consisted of 104,211 women (unweighted number) representing 5,032,562 women (weighted number).
Women who delivered multiple births (e.g., twins,
triplets) were excluded from the analysis, as consistent
with the literature [25, 26]. This study analyzed a deidentified publicly available data and was approved as
exempt by the Institutional Review Board at Virginia
Commonwealth University.
The exposure, maternal pre-pregnancy BMI was determined by self-report weight and height prior to
pregnancy (kilograms/meters2). Participants were asked,
“Just before you got pregnant with your new baby, how
much did you weigh?” and “How tall are you without
shoes?” Using BMI classifications from the World Health
Organization, pre-pregnancy BMI was categorized as
underweight (<18.5 kg/m2), normal weight (18.5–
24.9 kg/m2), overweight (25.0–29.9 (kg/m2) and obese
(≥30.0 kg/m2) [27].
The outcome of interest was the frequency of multivitamin use one month prior to pregnancy. Women
were asked, “During the month before you got pregnant
with your new baby, how many times a week did you
take a multivitamin, a prenatal vitamin, or a folic acid
vitamin?” Consistent with the literature, responses were
categorized into four levels: “I didn’t take a multivitamins, prenatal vitamins or folic acid vitamins at all” (i.e.,
Not at all), “1 to 3 times a week”, “4 to 6 times a week”,
or “every day of the week” [28].
Covariates examined included maternal sociodemographic factors, access to resources and care,
behavioral and lifestyle factors, reproductive health
factors and medical complications [15, 29–31]. Sociodemographic factors included maternal age (≤19; 20–24;
25–29; 30–35; >35), race/ethnicity (White non-Hispanic;
Black non-Hispanic; Hispanic; other non-Hispanic), education (<high school; high school; >high school), marital
status (married; not married), and household income level
(<20,000; 20,000–34,999; 35,000–49,999; ≥50,000). Factors
related to access to care and services included health insurance 12 months before pregnancy (private; Medicaid;
multiple; other; none). Maternal health behaviors prior to
pregnancy consisted of smoking (yes; no), drinking alcohol
(yes; no), dieting, i.e., changing eating habits any time during the 12 months prior to pregnancy (yes; no), and exercise habits, i.e., exercising three or more days of the week
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any time during the last 12 months before pregnancy (yes;
no). Maternal health conditions included preconception
morbidities such as diabetes (yes; no) and hypertension
(yes; no). Previous live pregnancy, pregnancy intention
and intimate partner violence were also evaluated as
confounders.
All analyses were conducted using SAS statistical software version 9.4 to account for the complex survey
design. Descriptive statistics including unweighted frequencies and weighted percentages were generated to
assess the distribution of maternal characteristics and
multivitamin use. Multinomial logistic regression models
for the outcome of interest were used to obtain crude
and adjusted odds ratios (COR and AOR, respectively)
and 95 % confidence intervals (CI). Adjusted estimates
controlled for domains of covariates such as maternal
socio-demographic characteristics, medical-reproductive
factors, and socio-behavioral characteristics.

Results
The majority of the study population was between the
ages of 20–29 years (53 %), Non-Hispanic White (60 %),
married (61 %), reported high school or more education
(58 %), earned less than $50,000 (64 %), and privately insured (56 %) (Table 1). Approximately 4.4 % of women
were underweight, 50.4 % were normal weight, 24.1 %
were overweight, and 21.2 % obese. More than half of
women (55.4 %) did not take multivitamins at any time,
8.4 % used multivitamins 1–3 times per week, 6.1 %
used multivitamins 4–6 times per week, and 30.2 % used
multivitamins every day. Multivitamin intake was
strongly associated with socio-demographic characteristics (e.g., marital status, income, race/ethnicity),
medical-reproductive (e.g., parity, pre-pregnancy diabetes), and social-behavioral factors (e.g., smoking
prior to pregnancy, intimate partner violence) (Table 2).
Pre-pregnancy BMI was significantly associated with age,
race, marital status, education, income, insurance, parity,
pre-pregnancy diabetes, pre-pregnancy hypertension,
pregnancy intention, smoking prior to pregnancy, alcohol use, exercise, dieting, and intimate partner violence (Table 3).
The unadjusted analyses showed a statistically significant association between pre-pregnancy BMI and multivitamin use (Table 4). Underweight and obese women
were 1.6 times as likely to report no multivitamin use
compared to women of normal weight (COR = 1.6, 95 %
CI = 1.4–1.8; COR = 1.6, 95 % CI = 1.5–1.7, respectively).
In addition, overweight women had 1.3 times the odds
of reporting no intake compared to women with normal
BMI (COR = 1.3, 95 % CI = 1.2–1.4). When controlling
for socio-demographic characteristics such as maternal
age, race, marital status, education, income, and health
insurance, the odds of non-adherence to multivitamin
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Table 1 Distribution of the study population characteristics
Total Weighted N = 5 032 562
%
Age
≤ 19

9.3

20–24

22.9

25–29

29.7

30–35

24.7

> 35

13.9

Race/Ethnicity
White, non-Hispanic

60.4

Black, non-Hispanic

13.7

Hispanic

17.8

Other, non-Hispanic

8.2

Married

61.0

Education
< High school

15.8

High school

26.3

> High school

57.9

Income
< $20,000

36.2

$20,000–34,999

17.0

$35,000–49,999

10.3

v ≥ $50,000

36.5

Pre-pregnancy Insurance
Private

55.9

Medicaid

15.6

Other

1.9

Multiple

3.4

No insurance

23.2

Previous live birth
0

42.0

v1 - 2

47.5

≥3

10.6

Pre-pregnancy diabetes

2.2

Pre-pregnancy hypertension

8.9

Unintended pregnancy

42.5

Pre-pregnancy smoking

24.6

Average number of alcohol drink/week
None

17.0

Up to 3

67.7

4 or more

15.3

Pre-pregnancy dieting

28.5

Pre-pregnancy exercising

42.2

Intimate partner violence

3.0

Weighted N = adjusted for the complex sampling design and represents the
total population that the sampled was derived from
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use stayed significant for overweight and obese women
(AOR = 1.2, 95 % CI = 1.1–1.3; AOR = 1.4, 95 % CI =
1.3–1.5, respectively). However, estimates were no longer
significant for the underweight group (AOR = 1.2, 95 %
CI = 1.0–1.4). After additionally adjusting for medicalreproductive factors such as previous live birth, pregnancy intention, pre-pregnancy diabetes, and prepregnancy hypertension, the estimates remained consistent for overweight (AOR = 1.2, 95 % CI = 1.2–1.3) and
obese women (AOR = 1.5, 95 % CI = 1.03–1.6). In fact,
overweight and obese women were significantly more
likely to report no multivitamin use compared to normal
weight women (AOR = 1.2, 95 % CI = 1.1–1.3; AOR = 1.4,
95 % CI = 1.2–1.5, respectively) even after controlling for
all covariates including socio-demographic characteristics,
medical-reproductive factors, and socio-behavioral characteristics (i.e., smoking, alcohol consumption, diet, exercise,
and intimate partner violence).
The odds of inadequate multivitamin supplementation,
specifically 1–3 times per week, were higher for obese
women compared to normal weight women (COR = 1.3,
95 % CI = 1.1–1.4). Similar estimates were obtained after
adjusting for socio-demographic and medical-reproductive
factors (AOR = 1.2, 95 % CI = 1.1–1.3). However, there were
no longer significant differences between obese and normal
weight women in fully adjusted models (AOR = 1.1, 95 %
CI = 0.9–1.3). The odds of multivitamin use (4–6 times per
week) remained non-significant for all different weight
groups, even after controlling for all aforementioned
factors.

Discussion
We found that obese and overweight women were less
likely to follow the recommended use of preconception
multivitamins compared to normal weight women. These
findings are consistent with previous studies [20, 21]. Unlike previous studies, this analysis employed data from a
national survey that provided a large sample size and
representative study population. For instance, contrary to
findings from Farah et al. which were based on a small
sample of Caucasian women, the current study provided
estimates that are more generalizable to the U.S. population [20].
Adequate multivitamin use one month prior to pregnancy has well-known positive benefits for both mothers
and developing infants. However, the CDC reported that
63 % of women do not take the recommended amount
of multivitamin one month prior to pregnancy [6]. This
is consistent with our study finding that more than half
of the women did not take multivitamin during the
preconception period. While there are several possible
reasons for lack of multivitamin use (e.g., simply forgetting), a growing body of literature has attributed this
lack of adherence to unintended pregnancies [32–34].
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Table 2 Prevalence of multivitamin intake by maternal characteristics
No intake
n = 2 946 523

1–3 times/week
n = 444 399

4–6 times/week
n = 323 867

Every day
n = 1 607 653

P-value

Weighted row %
Body mass index

<.0001

Underweight

61.6

8.5

4.6

25.3

Normal Weight

51.09

8.50

6.92

33.49

Overweight

56.47

8.33

6.07

29.13

Obese

60.9

8.3

5.0

25.8

77.6

5.6

1.9

14.9

Socio-demographic
Age

<.0001
≤ 19
20–24

71.8

7.3

3.8

17.1

25─29

54.3

8.7

6.2

30.8

30–35

42.3

9.2

8.0

40.5

> 35

38.5

9.8

8.9

42.8

White, non-Hispanic

49.2

8.6

7.5

34.7

Black, non-Hispanic

66.6

9.1

3.5

20.8

Hispanic

66.0

7.2

3.9

22.9

Other, non-Hispanic

54.1

8.2

6.1

31.6

Race/Ethnicity

<.0001

Married

<.0001

Yes

43.5

9.2

8.2

39.1

Other

73.2

7.1

2.9

16.8

71.0

6.7

2.9

19.4

Education
< High school

<.0001

High school

68.6

7.1

3.6

20.7

> High school

44.2

9.5

8.2

38.1

< $20,000

72.2

7.5

3.1

17.2

$20,000–34,999

62.7

8.6

5.2

23.5

$35,000–49,999

53.1

9.6

7.6

29.7

≥ $50,000

33.0

9.0

9.8

48.2

Income

<.0001

Pre-pregnancy Insurance

<.0001

Private

42.8

9.0

8.2

40.0

Medicaid

66.8

8.1

3.6

21.5

Other

61.3

8.7

4.5

25.5

Multiple

57.4

8.1

3.9

30.6

No insurance

73.5

7.2

3.6

15.7

54.8

7.1

5.4

32.7

Medical-reproductive
Previous live birth
0

<.0001

1–2

54.6

9.0

6.6

29.8

≥3

60.94

10.1

6.5

22.54
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Table 2 Prevalence of multivitamin intake by maternal characteristics (Continued)
Pre-pregnancy diabetes

<.0001

No

55.5

8.3

6.1

30.1

Yes

50.9

8.6

4.7

35.8

No

56.1

8.3

6.2

29.4

Yes

47.3

8.7

4.9

39.1

Pre-pregnancy hypertension

<.0001

Pregnancy intention

<.0001

Unintended

71.9

8.1

4.00

16.0

Intended

43.0

8.5

7.6

40.9

Socio-behavioral
Pre-pregnancy smoking

<.0001

No

49.9

8.8

6.8

34.5

Yes

72.5

6.9

3.9

16.7

None

55.1

6.9

5.2

32.8

Up to 3

52.5

8.6

7.2

31.7

v4 or more

58.5

8.1

7.0

26.4

No

57.2

7.8

5.7

29.3

Yes

50.6

9.8

7.1

32.5

Average # of alcohol drink/week

<.0001

Pre-pregnancy dieting

<.0001

Pre-pregnancy exercising

<.0001

No

63.1

7.8

4.8

24.3

Yes

44.5

9.0

7.9

38.6

No

54.6

8.4

6.2

30.8

Yes

72.9

7.4

3.1

16.6

Intimate partner violence

<.0001

Weighted N = adjusted for the complex sampling design and represents the total population that the sampled was derived from

Previous studies reported that obese women have higher
rates of unintended pregnancies compared to their normal weight counterpart. Huber et al. analyzed PRAMS
database and reported that obese women are at higher
risk of unintended pregnancy compared to normal
weight women (AOR = 1.75, 95 % CI = 1.21–2.52) [33].
Similarly, Garbers et al. found that obese women had
more than twice the odds of unintended pregnancy
(AOR = 2.81, 95 % CI = 1.41–5.60) [35]. Nevertheless,
findings from the current study demonstrated that obese
women had a higher odds of not using multivitamins
even after adjusting for pregnancy intention.
Another possible explanation for the association
between obesity and lack of multivitamin use may be
that overweight and obese women are less likely to take
dietary supplements. This was demonstrated by Radimer
et al. who reported that obese adults were less likely to
engage in healthy behaviors including multivitamin use
[36]. Furthermore, it is also possible that overweight
and obese women may not receive the appropriate

counseling for preconception multivitamin use. The
CDC reports that obese/overweight women are more
likely to receive suboptimal preconception care in
contrast to normal weight women [6]. Health care
providers may play an important role in multivitamin
use prior to pregnancy. However, only one of six obstetrician/gynecologists or family physicians provides
preconception care to prenatal care patients [37].
The strengths of this study consist of having a large
nationally-representative data that utilizes standardized
methods of data collection. These methods allow for
optimal comparison among participating states. The
PRAMS data also allowed this study to account for
important socio-demographic, medical, and high-risk
behavioral factors. Despite these strengths, the study has
some limitations. The cross-sectional design makes it
difficult to determine causality between exposure and
outcome. However, this study included women who had
a live birth and the question about preconception multivitamin use clearly referred to one month prior to
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Table 3 Maternal characteristics by Body Mass Index
Underweight
n = 219 560

Normal Weight
n = 2 534 187

Overweight
n = 1 212 554

Obese
n = 1 066 261

P-value

Weighted row %
Socio-demographic
Age

<.0001
≤ 19

17.4

10.9

7.4

5.8

20–24

30.9

22.2

23.1

22.7

25–29

26.7

28.5

29.8

31.0

30–35

16.8

25.0

24.7

25.4

> 35

8.3

13.4

15.0

15.1

Race/Ethnicity

<.0001

White, non-Hispanic

60.4

63.7

56.0

56.2

Black, non-Hispanic

11.7

10.8

15.6

18.7

Hispanic

14.8

16.0

20.4

19.8

Other, non-Hispanic

13.1

9.4

7.1

5.4

Yes

52.2

63.5

60.5

57.4

Other

47.8

36.5

39.5

42.6

Married

<.0001

Education

<.0001

< High school

22.2

15.1

16.1

16.0

High school

29.4

23.6

27.2

31.2

> High school

48.4

61.4

56.6

52.9

Income

<.0001

< $20,000

48.9

32.9

36.7

40.8

$20,000–34,999

15.0

15.4

17.7

20.4

$35,000–49,999

9.1

9.8

10.6

11.3

≥ $50,000

27.0

41.9

35.1

27.5

45.3

60.0

54.8

49.3

Medicaid

20.9

13.9

15.2

19.1

Other

2.11

1.9

1.9

2.1

Pre-pregnancy Insurance
Private

<.0001

Multiple

3.6

3.2

3.3

3.9

No insurance

28.0

21.0

24.8

25.6

Medical-reproductive
Previous live birth

<.0001

0

51.6

45.8

38.7

34.7

1–2

40.8

45.7

49.0

51.4

≥3
Pre-pregnancy diabetes

7.6

8.6

12.3

13.9

1.6

1.4

2.2

3.9

<.0001

Pre-pregnancy hypertension

7.1

7.1

9.0

13.3

<.0001

Unintended Pregnancy

50.0

40.6

42.0

45.9

<.0001

30.7

22.5

24.5

28.3

<.0001

Socio-behavioral
Pre-pregnancy smoking
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Table 3 Maternal characteristics by Body Mass Index (Continued)
Average # of alcohol drink/week

<.0001

None

17.7

15.6

17.2

19.8

Up to 3

68.9

67.5

67.3

68.3

4 or more

11.4

15.0

13.4

10.3

8.1

21.0

36.5

41.4

Pre-pregnancy dieting

<.0001

Pre-pregnancy exercising

31.0

45.8

42.8

35.3

<.0001

Intimate partner violence

4.4

2.8

3.2

3.2

0.0085

Weighted N = adjusted for the complex sampling design and represents the total population that the sampled was derived from

pregnancy. Another limitation of the study is that BMI
and multivitamin use were both self-reported. It is possible that overweight and obese women may be underreporting their weight because of social desirability bias
which may bias the estimate toward the null. Additionally, PRAMS questionnaire is administered several
months after delivery, making women’s answers subject
to recall bias. However, limiting the recall period to no
longer than one year might minimize recall bias. In fact,
PRAMS typically contacts women two to four months
Table 4 Adjusted logistic regression models for non-adherence
to multivitamin use among BMI Groups
Underweight

Overweight

Obese

CORa
No intake

1.6 (1.4–1.8)

1.3 (1.2–1.4)

1.6 (1.5–1.7)

1–3 times/week

1.3 (1.0–1.6)

1.1 (1.0–1.2)

1.3 (1.1–1.4)

4–6 times/week

0.9 (0.7–1.1)

1.0 (0.9–1.1)

0.9 (0.8–1.1)

No intake

1.2 (1.0–1.4)

1.2 (1.1–1.3)

1.4 (1.3–1.5)

1–3 times/week

1.2 (1.0–1.5)

1.1 (1.0–1.2)

1.2 (1.0–1.3)

4–6 times/week

1.0 (0.8–1.2)

1.0 (0.9–1.1)

1.0 (0.9–1.1)

No intake

1.2 (1.0–1.4)

1.2 (1.2–1.3)

1.5 (1.3–1.6)

1–3 times/week

1.2 (1.0–1.5)

1.1 (1.0–1.2)

1.2 (1.1–1.3)

4–6 times/week

1.0 (0.8–1.3)

1.0 (0.9–1.1)

1.0 (0.9–1.2)

No intake

1.1 (0.9–1.4)

1.2 (1.1–1.3)

1.4 (1.2–1.5)

1–3 times/week

1.4 (1.0–1.8)

1.1 (0.9–1.2)

1.1 (0.9–1.3)

4–6 times/week

1.1 (0.8–1.5)

1.0 (0.9–1.2)

1.0 (0.9–1.2)

AORb

AORc

AORd

Daily intake is referent outcome group; bolded estimates indicate
statistical significance
a
Crude odds ratio of multivitamin intake
b
Adjusted for socio-demographic characteristics (age, marital status, race/ethnicity,
education, income, and health insurance)
c
Adjusted for socio-demographic characteristics and medical-reproductive
factors (previous live birth, pregnancy intention, pre-pregnancy diabetes, and
pre-pregnancy hypertension)
d
Adjusted for socio-demographic characteristics, medical-reproductive factors,
and socio-behavioral characteristics (pre-pregnancy smoking, average # of
alcohol drink per week, pre-pregnancy dieting, pre-pregnancy exercising, and
intimate partner violence)

after delivery [38, 39]. Lastly, the effect of preconception
counseling on multivitamin use may have affected the
results but were unavailable in the data. Health education and counseling on positive health behaviors during
perinatal care visits may be of interest for future
research.

Conclusions
In summary, overweight and obese women are less likely
to follow the universal recommendation for multivitamin
use one month before pregnancy. This behavior might
increase the risk for serious but preventable outcomes in
infants, such as neural tube defects, anencephaly, multiple birth defects, small for gestation, and low birth
weight. More research and well-designed studies are
needed to investigate in detail the reasons for inadequate
multivitamin use in obese/overweight women during the
preconception period. Knowing the motivations underlying this problem would help health policy makers implement a proper intervention. However, health care
providers and policy makers need to raise awareness of
this significant health problem. Furthermore, all health
care professional should enhance preconception care
during well–woman visits or other routine visits, and
particular attention should be given to obese women.
Preconception counseling presents an opportunity to
discuss healthy eating and healthy weight, as well as the
benefit of daily multivitamin intake before pregnancy.
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